Open-label Uncontrolled Trial to Evaluate Pharmacokinetics, Pharmacodynamics, Safety, and Activity of Efgartigimod in Children From 2 to Less Than 18 Years of Age With Generalized Myasthenia Gravis- ARGX-113-2006.
For more information or to register for the study, contact Study Coordinator Manisha Chopra
Manisha Chopra